Pulse Prescription drugs has acquired approval from the Drug Controller Normal of India (DCGI) for its nano-carrier entrapped Vitamin D3 oral dispersion.
“Medical research have demonstrated 50-60 per cent greater serum vitamin D ranges with nano-carrier entrapped Vitamin D3 oral dispersion in comparison with typical formulations,’’ the Hyderabad-based firm stated on Thursday. The product is being manufactured by Pulse Prescription drugs in Roorkee, Baddi and Hyderabad.
The proprietary Aqueol platform know-how of the corporate is particularly designed to successfully/ ship lipophilic compounds in water-based mediums. Pulse makes use of nanotechnology to enhance efficiency of the drug, its bioavailability and the general affected person expertise.
Past Vitamin D3, Pulse is making use of these platforms to different important vitamins (Vitamin K2-7, Vitamin B12 and Iron) and widely-used medicines (Paracetamol, Diclofenac and Ibuprofen), a launch stated.
Printed on August 20, 2026
